ANAPLASTIC LYMPHOMA KINASE
Clinical trials for ANAPLASTIC LYMPHOMA KINASE explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC LYMPHOMA KINASE trials appear
Sign up with your email to follow new studies for ANAPLASTIC LYMPHOMA KINASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets hard-to-treat lymphoma
Disease control Recruiting nowThis study tests two drugs, alectinib and duvelisib, together in people with a rare type of blood cancer called ALK+ anaplastic large cell lymphoma that has come back or not responded to prior treatment. The goal is to find the safest dose and see if the combination can control t…
Matched conditions: ANAPLASTIC LYMPHOMA KINASE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Lung cancer drug brigatinib under Real-World watch in south korea
Disease control Recruiting nowThis study monitors adults with advanced ALK-positive non-small cell lung cancer who are starting brigatinib for the first time. Researchers will track side effects and measure how often tumors shrink or disappear. The goal is to confirm the drug's safety and effectiveness in eve…
Matched conditions: ANAPLASTIC LYMPHOMA KINASE
Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 10:30 UTC